← FDA DRUG APPROVALS

FDA ANDA · ANDA202077

LATANOPROST

Sponsor: CARNEGIE

APPLICATION
ANDA202077
TYPE
ANDA
ORIGINAL APPROVAL
2013-02-11
LATEST ACTION
2015-12-17
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

LATANOPROSTDiscontinued
LATANOPROST 0.005% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2015-12-17Labeling · Supplement 1 · standardAP
2013-02-11Not Applicable · OriginalAP
2013-02-11Supplement 11AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →